# Owl Capital

> Owl Capital is a VC fund in Menlo Park backing Health Care and Banking. See 5 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Menlo Park, United States
- Total investments: 5
- Last investment: Jul 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/owl-capital/
- X (Twitter): https://twitter.com/OwlCapitalGroup
- Website: https://owlcapital.com/
- Facebook: https://www.facebook.com/Owl-Capital-109484577130283

Owl Capital is a venture capital firm focusing on early stage investments in the digital health, fintech, and enterprise technology space.

## Contacts

5 contacts available for Owl Capital. Shizune tracks 1 team members at Owl Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/owl-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 60% |
| Banking | 1 | 20% |
| Content | 1 | 20% |
| Medical | 1 | 20% |
| Podcast | 1 | 20% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 40% |
| Series A | 2 | 40% |
| Series B | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jennifer Fonstad | Managing Partner | 18 | https://shizune.co/investors/profile/jennifer-scott-fonstad |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Othello | Othello.ai is the real-time AI sales coach for live phone and video calls. | $8M | Seed | Jul 14, 2026 |  |
| Salvo Health | Salvo is emerging as the leader in helping GI providers leap into a hybrid-care vision of the future of medicine, providing brick & mortar clinics with an easy to implement continuous care platform that saves time, increases revenue and improves patient outcomes.The company has announced agreements with 771 GI’s, representing 15% of allindependent GI’s in the US, to deploy wraparound care for their clinic patients. Included in its customers are five of the largest GI practices in the country, together seeing over 1.1 million GI patients a year. Salvo provides the tech and care delivery for modern, interdisciplinary care to treat chronic conditions that have surged in cost and prevalence: --IBS and IBD (over 40M affected) -- GERD and Celiac (over 50M affected) --MASH/MASLD, what was previously called “fatty liver disease” (over 80M) --Obesity (over 100M) The care benefits patients (76% of patients reported improved symptoms, five accepted medical conference abstracts on outcomes), generates incremental profit for practices (over $2M EBITDA improvement for a 100 GI practice), and reduces total healthcare costs (79% drop in GI-related ER utilization). | $8.5M | Series A | Jan 22, 2026 |  |
| Deciduous Therapeutics | Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune-modulatory therapies that clear senescent cells and promote a healthy lifespan. Deciduous is led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, a five-time biotech founder. | $10M | Seed | Dec 31, 2022 |  |
| Lemonada Media | Lemonada Media is a podcast network that shares the unfiltered version of the human experience. Lemonada's podcasts feature first-person narratives that live on through an engaged community and shares content that gives listeners a sense of understanding about different experiences of others and makes them relate to it, hence allowinglisteners to understand multiple human experiences and make them feel good and take lessons for their own experiences. | $8M | Series A | Jan 27, 2022 |  |
| Welcome Tech | Welcome Tech is a digital platform that builds data-driven services for immigrant workforces. The company offers access to essential services, including healthcare, jobs, education, and financial tools. With over 4.5 million registered members and a growing base of enterprise partners, it enables inclusive economic participation while helpingemployers recruit, retain, and serve an increasingly diverse workforce. | $35M | Series B | Apr 21, 2021 |  |

5 of 5 investments shown.

## Co-investors
- [City Light Capital](https://shizune.co/investors/profile/city-light-capital) — VC Fund, 2 deals together
- [Torch Capital](https://shizune.co/investors/profile/torch-capital) — VC Fund, 2 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 1 deal together
- [Andreessen Horowitz](https://shizune.co/investors/profile/andreessen-horowitz) — VC Fund, 1 deal together
- [1745 Ventures](https://shizune.co/investors/profile/bertelsmann-digital-media-investments) — VC Fund, 1 deal together
- [Blue Collective](https://shizune.co/investors/profile/blue-collective) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Owl Capital invest in?

Owl Capital invests primarily in Health Care, Banking and Content startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Owl Capital?

Public channels for Owl Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Owl Capital?

The team at Owl Capital includes Jennifer Fonstad (Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co